---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-034280"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2022-10-14T23:59:59+00:00"
generated_at: "2026-06-23T03:31:54.217644+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Organovo shareholders approve 2022 equity plan; Cohen and Gobel elected directors

## Summary
- Stockholders approved 2022 Equity Incentive Plan with 94.35% of votes cast; 1,236,738 shares reserved.
- Douglas Jay Cohen and David Gobel elected as Class II directors with votes for 1,845,765 and 1,879,778 respectively.
- Mayer Hoffman McCann P.C. ratified as auditor for fiscal 2023 with 98.36% of votes cast.
- Advisory vote on executive compensation approved with 92.40% of votes cast.
- 2021 Inducement Plan share reserve reduced from 750,000 to 51,000 shares effective October 12.

## SEC filing metadata
- accession: 0001564590-22-034280
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2022-10-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000156459022034280/0001564590-22-034280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000156459022034280/onvo-8k_20221012.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-034280
- JSON: https://secwatch.observer/filing/0001564590-22-034280.json
- Plain text: https://secwatch.observer/filing/0001564590-22-034280.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.